Enveda CEO Viswa Colluru on the Mission to Decode Nature's Pharmacy
Inside the ICE House
•
18m
Enveda Biosciences is using AI to decode nature’s vast chemical library and transform it into breakthrough medicines. Founded in 2019 by Viswa Colluru, the company is advancing first-in-class therapies like ENV-294 while cutting the time and cost of drug discovery. Colluru joins Inside the ICE House to share how Enveda is reimagining the playbook for modern medicine and building a healthier future for patients worldwide.
Up Next in Inside the ICE House
-
Nimbus CEO Abbas Kazimi on Leading th...
Nimbus Therapeutics is transforming drug discovery with computational chemistry and AI to design small molecules that precisely target disease. CEO Abbas Kazimi, who took the helm in March, is driving a “fail fast” approach that balances discipline with innovation. He joins Inside the ICE House t...
-
Back Roads and Better Angels: Frank B...
Driven by a desire to explore the ties that bind and the divides that separate 330 million Americans, Frank Barry embarked on a seven-month, 10,000-mile journey across the Lincoln Highway, witnessing firsthand the resilience and fragility of our democracy during the Covid-19 pandemic. Four years ...
-
Cigna's Brian Evanko on Healthcare Af...
